Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-02-23 @ 11:34 AM
Study NCT ID:
NCT00061932
Status:
COMPLETED
Last Update Posted:
2021-02-02
First Post:
2003-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Adenocarcinoma of the Gastroesophageal Junction | View |
| None | Diffuse Adenocarcinoma of the Stomach | View |
| None | Intestinal Adenocarcinoma of the Stomach | View |
| None | Mixed Adenocarcinoma of the Stomach | View |
| None | Recurrent Gastric Cancer | View |
| None | Stage IIIB Gastric Cancer | View |
| None | Stage IIIC Gastric Cancer | View |
| None | Stage IV Gastric Cancer | View |
Keywords: